142852-50-4O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2PMBLXLOXUGVTGB-UHFFFAOYSA-NZanapezil is a member of piperidines.
142852-50-4DTXSID90861521CHEMBL75013CHEBI:188916Zanapezil is an acetylcholinesterase inhibitor being developed by Takeda for the treatment of dementia in subjects with Alzheimer’s disease. In May 2003, the company discontinued development of the compound due to a lack of a dose-dependent effect in the trials.
Zanapezil inhibits the degradation of acetylcholine, a neurotransmitter, to prevent the reduction of cerebral acetylcholine levels and to enhance the mental function of patients with dementia. It is expected to act selectively on the central nervous system, resulting in fewer peripheral adverse reactions.
使用Zanapezil is a acetylcholinesterase inhibitor that is a potential drug for treating Alzheimer disease.
現在のフィルター条件では反応記録がありません。
読み込み中…